The introduction of nicotinamide as a nicotine substitution in e-cigarette and smokeless solutions signifies a substantial regulatory challenge for the FDA. Nicotinamide doesn't have nicotinic receptor agonist action and is understood to act as a sedative at significant dosages6. The promises pr